These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20082131)

  • 1. The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.
    Veasey RA; Arya A; Freemantle N; Silberbauer J; Patel NR; Lloyd GW; Sulke AN
    J Interv Card Electrophysiol; 2010 Jun; 28(1):51-7. PubMed ID: 20082131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study.
    Russo V; Papa AA; Rago A; Ciardiello C; Nigro G
    Heart Rhythm; 2018 Jul; 15(7):962-968. PubMed ID: 29524476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.
    Chen S; Wang Z; Kiuchi MG; Andrea BR; Krucoff MW; Liu S; Pürerfellner H
    Clin Res Cardiol; 2016 Aug; 105(8):687-698. PubMed ID: 26913516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
    Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L;
    Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial pacing for the prevention and termination of atrial fibrillation.
    Savelieva I; Camm AJ
    Am J Geriatr Cardiol; 2002; 11(6):380-98. PubMed ID: 12417845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?
    Russo V; Rago A; Papa AA; Politano L; Golino P; Russo MG; Calabrò R; Nigro G
    Kardiol Pol; 2013; 71(11):1147-53. PubMed ID: 24297712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
    de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
    Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of long-lasting atrial fibrillation through antitachycardia pacing in DDDR pacemakers.
    Boriani G; Sakamoto Y; Botto G; Komura S; Pieragnoli P; Minamiguchi H; Iacopino S; Noma T; Infusino T; Takahashi Y; Facchin D; De Rosa F; Pisanò E; Meloni S; Biffi M
    Int J Clin Pract; 2021 Mar; 75(3):e13820. PubMed ID: 33164319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation.
    Kale M; Bennett DH
    Europace; 2003 Apr; 5(2):123-31. PubMed ID: 12633635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A preliminary study on the role of anti-atrial fibrillation pacemaker in the prevention of atrial tachyarrhythmia].
    Yang JF; Tong JB; Wang ZL; Zhou T; Li M; Wu SJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):824-6. PubMed ID: 16266459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between high-frequency right ventricular pacing and paroxysmal atrial fibrillation burden.
    Silberbauer J; Veasey RA; Freemantle N; Arya A; Boodhoo L; Sulke N
    Europace; 2009 Nov; 11(11):1456-61. PubMed ID: 19666638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the atrial blanking time on the detection of atrial fibrillation in dual chamber pacing.
    Nowak B; Kracker S; Rippin G; Horstick G; Vincent A; Geil S; Himmrich E; Meyer J
    Pacing Clin Electrophysiol; 2001 Apr; 24(4 Pt 1):496-9. PubMed ID: 11341088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical Value of Algorithms of Minimization of Right Ventricular Pacing in Patients With Sick Sinus Syndrome and History of Atrial Fibrillation].
    Ivanchina AE; Kopylov FY; Volkova AL; Samojlenko IV; Syrkin AL
    Kardiologiia; 2018 Aug; (8):58-63. PubMed ID: 30131043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.